1. Jarroux, J., Morillon, A., and Pinskaya, M. (2017). History, Discovery, and Classification of lncRNAs. Adv. Exp. Med. Biol. 1008, 1–46. 10.1007/978-981-10-5203-3_1.
2. Gourvest, M., Brousset, P., and Bousquet, M. (2019). Long Noncoding RNAs in Acute Myeloid Leukemia: Functional Characterization and Clinical Relevance. Cancers 11, 1638. 10.3390/cancers11111638.
3. Cabili, M.N., Dunagin, M.C., McClanahan, P.D., Biaesch, A., Padovan-Merhar, O., Regev, A., Rinn, J.L., and Raj, A. (2015). Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biol. 16, 20. 10.1186/s13059-015-0586-4.
4. Heesch, S. van, Iterson, M. van, Jacobi, J., Boymans, S., Essers, P.B., Bruijn, E. de, Hao, W., MacInnes, A.W., Cuppen, E., and Simonis, M. (2014). Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes. Genome Biol. 15, 1–12. 10.1186/gb-2014-15-1-r6.
5. Szcześniak, M.W., Wanowska, E., Mukherjee, N., Ohler, U., and Makałowska, I. (2020). Towards a deeper annotation of human lncRNAs. Biochim. Biophys. Acta BBA - Gene Regul. Mech. 1863, 194385. 10.1016/j.bbagrm.2019.05.003.
6. Noh, J.H., Kim, K.M., McClusky, W.G., Abdelmohsen, K., and Gorospe, M. (2018). Cytoplasmic functions of long noncoding RNAs. Wiley Interdiscip. Rev. RNA 9, e1471. 10.1002/wrna.1471.
7. Carlevaro-Fita, J., Rahim, A., Guigó, R., Vardy, L.A., and Johnson, R. (2016). Cytoplasmic long noncoding RNAs are frequently bound to and degraded at ribosomes in human cells. RNA N. Y. N 22, 867–882. 10.1261/rna.053561.115.
8. Ingolia, N.T., Brar, G.A., Stern-Ginossar, N., Harris, M.S., Talhouarne, G.J.S., Jackson, S.E., Wills, M.R., and Weissman, J.S. (2014). Ribosome Profiling Reveals Pervasive Translation Outside of Annotated Protein-Coding Genes. Cell Rep. 8, 1365–1379. 10.1016/j.celrep.2014.07.045.
9. Zeng, C., Fukunaga, T., and Hamada, M. (2018). Identification and analysis of ribosome-associated lncRNAs using ribosome profiling data. BMC Genomics 19. 10.1186/s12864-018-4765-z.
10. Chen, J., Brunner, A.-D., Cogan, J.Z., Nuñez, J.K., Fields, A.P., Adamson, B., Itzhak, D.N., Li, J.Y., Mann, M., Leonetti, M.D., et al. (2020). Pervasive functional translation of noncanonical human open reading frames. Science 367, 1140–1146. 10.1126/science.aay0262.
11. Othoum, G., Coonrod, E., Zhao, S., Dang, H.X., and Maher, C.A. (2020). Pan-cancer proteogenomic analysis reveals long and circular noncoding RNAs encoding peptides. NAR Cancer 2, zcaa015. 10.1093/narcan/zcaa015.
12. Wu, P., Mo, Y., Peng, M., Tang, T., Zhong, Y., Deng, X., Xiong, F., Guo, C., Wu, X., Li, Y., et al. (2020). Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol. Cancer 19, 22. 10.1186/s12943-020-1147-3.
13. Heesch, S. van, Witte, F., Schneider-Lunitz, V., Schulz, J.F., Adami, E., Faber, A.B., Kirchner, M., Maatz, H., Blachut, S., Sandmann, C.-L., et al. (2019). The Translational Landscape of the Human Heart. Cell 178, 242-260.e29. 10.1016/j.cell.2019.05.010.
14. Wright, B.W., Yi, Z., Weissman, J.S., and Chen, J. (2022). The dark proteome: translation from noncanonical open reading frames. Trends Cell Biol. 32, 243–258. 10.1016/j.tcb.2021.10.010.
15. Wery, M., Descrimes, M., Vogt, N., Dallongeville, A.S., Gautheret, D., and Morillon, A. (2016). Nonsense-Mediated Decay Restricts LncRNA Levels in Yeast Unless Blocked by Double-Stranded RNA Structure. Mol. Cell 61. 10.1016/j.molcel.2015.12.020.
16. Andjus, S., Szachnowski, U., Vogt, N., Hatin, I., Papadopoulos, C., Lopes, A., Namy, O., Wery, M., and Morillon, A. (2022). Translation is a key determinant controlling the fate of cytoplasmic long non-coding RNAs. 2022.05.25.493276. 10.1101/2022.05.25.493276.
17. Clark, M.B., Johnston, R.L., Inostroza-Ponta, M., Fox, A.H., Fortini, E., Moscato, P., Dinger, M.E., and Mattick, J.S. (2012). Genome-wide analysis of long noncoding RNA stability. Genome Res. 22, 885–898. 10.1101/gr.131037.111.
18. Mukherjee, N., Calviello, L., Hirsekorn, A., de Pretis, S., Pelizzola, M., and Ohler, U. (2017). Integrative classification of human coding and noncoding genes through RNA metabolism profiles. Nat. Struct. Mol. Biol. 24, 86–96. 10.1038/nsmb.3325.
19. Tani, H., Mizutani, R., Salam, K.A., Tano, K., Ijiri, K., Wakamatsu, A., Isogai, T., Suzuki, Y., and Akimitsu, N. (2012). Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals. Genome Res. 22, 947–956. 10.1101/gr.130559.111.
20. Maekawa, S., Imamachi, N., Irie, T., Tani, H., Matsumoto, K., Mizutani, R., Imamura, K., Kakeda, M., Yada, T., Sugano, S., et al. (2015). Analysis of RNA decay factor mediated RNA stability contributions on RNA abundance. BMC Genomics 16, 154. 10.1186/s12864-015-1358-y.
21. Schlackow, M., Nojima, T., Gomes, T., Dhir, A., Carmo-Fonseca, M., and Proudfoot, N.J. (2017). Distinctive Patterns of Transcription and RNA Processing for Human lincRNAs. Mol. Cell 65, 25–38. 10.1016/j.molcel.2016.11.029.
22. Lubas, M., Damgaard, C.K., Tomecki, R., Cysewski, D., Jensen, T.H., and Dziembowski, A. (2013). Exonuclease hDIS3L2 specifies an exosome-independent 3′-5′ degradation pathway of human cytoplasmic mRNA. EMBO J. 32, 1855–1868. 10.1038/emboj.2013.135.
23. Szczepińska, T., Kalisiak, K., Tomecki, R., Labno, A., Borowski, L.S., Kulinski, T.M., Adamska, D., Kosinska, J., and Dziembowski, A. (2015). DIS3 shapes the RNA polymerase II transcriptome in humans by degrading a variety of unwanted transcripts. Genome Res. 25, 1622–1633. 10.1101/gr.189597.115.
24. Tomecki, R., Kristiansen, M.S., Lykke-Andersen, S., Chlebowski, A., Larsen, K.M., Szczesny, R.J., Drazkowska, K., Pastula, A., Andersen, J.S., Stepien, P.P., et al. (2010). The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L. EMBO J. 29, 2342–2357. 10.1038/emboj.2010.121.
25. Chlebowski, A., Lubas, M., Jensen, T.H., and Dziembowski, A. (2013). RNA decay machines: the exosome. Biochim. Biophys. Acta 1829, 552–560. 10.1016/j.bbagrm.2013.01.006.
26. Łabno, A., Warkocki, Z., Kuliński, T., Krawczyk, P.S., Bijata, K., Tomecki, R., and Dziembowski, A. (2016). Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs. Nucleic Acids Res. 44, 10437–10453. 10.1093/nar/gkw649.
27. Ustianenko, D., Pasulka, J., Feketova, Z., Bednarik, L., Zigackova, D., Fortova, A., Zavolan, M., and Vanacova, S. (2016). TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. EMBO J. 35, 2179–2191. 10.15252/embj.201694857.
28. Nagarajan, V.K., Jones, C.I., Newbury, S.F., and Green, P.J. XRN 5′ → 3′ exoribonucleases: Structure, mechanisms and functions. Biochim. Biophys. Acta BBA - Gene Regul. Mech. 10.1016/j.bbagrm.2013.03.005.
29. Eaton, J.D., Davidson, L., Bauer, D.L.V., Natsume, T., Kanemaki, M.T., and West, S. (2018). Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity. Genes Dev. 32, 127–139. 10.1101/gad.308528.117.
30. Łabno, A., Tomecki, R., and Dziembowski, A. (2016). Cytoplasmic RNA decay pathways - Enzymes and mechanisms. Biochim. Biophys. Acta BBA - Mol. Cell Res. 1863, 3125–3147. 10.1016/j.bbamcr.2016.09.023.
31. Siwaszek, A., Ukleja, M., and Dziembowski, A. (2014). Proteins involved in the degradation of cytoplasmic mRNA in the major eukaryotic model systems. RNA Biol. 11, 1122–1136. 10.4161/rna.34406.
32. van Dijk, E.L., Chen, C.L., d’Aubenton-Carafa, Y., Gourvennec, S., Kwapisz, M., Roche, V., Bertrand, C., Silvain, M., Legoix-Né, P., Loeillet, S., et al. (2011). XUTs are a class of Xrn1-sensitive antisense regulatory non-coding RNA in yeast. Nature 475, 114–117. 10.1038/nature10118.
33. Szachnowski, U., Andus, S., Foretek, D., Morillon, A., and Wery, M. (2019). Endogenous RNAi pathway evolutionarily shapes the destiny of the antisense lncRNAs transcriptome. Life Sci. Alliance 2, e201900407. 10.26508/lsa.201900407.
34. Wery, M., Descrimes, M., Vogt, N., Dallongeville, A.-S., Gautheret, D., and Morillon, A. (2016). Nonsense-Mediated Decay Restricts LncRNA Levels in Yeast Unless Blocked by Double-Stranded RNA Structure. Mol. Cell 61, 379–392. 10.1016/j.molcel.2015.12.020.
35. Andjus, S., Szachnowski, U., Vogt, N., Hatin, I., Papadopoulos, C., Lopes, A., Namy, O., Wery, M., and Morillon, A. (2022). Translation is a key determinant controlling the fate of cytoplasmic long non-coding RNAs. 2022.05.25.493276. 10.1101/2022.05.25.493276.
36. Lykke-Andersen, S., Chen, Y., Ardal, B.R., Lilje, B., Waage, J., Sandelin, A., and Jensen, T.H. (2014). Human nonsense-mediated RNA decay initiates widely by endonucleolysis and targets snoRNA host genes. Genes Dev. 28, 2498–2517. 10.1101/gad.246538.114.
37. Pashler, A.L., Towler, B.P., Jones, C.I., Haime, H.J., Burgess, T., and Newbury, S.F. (2021). Genome-wide analyses of XRN1-sensitive targets in osteosarcoma cells identify disease-relevant transcripts containing G-rich motifs. RNA N. Y. N 27, 1265–1280. 10.1261/rna.078872.121.
38. Slomovic, S., Fremder, E., Staals, R.H.G., Pruijn, G.J.M., and Schuster, G. (2010). Addition of poly(A) and poly(A)-rich tails during RNA degradation in the cytoplasm of human cells. Proc. Natl. Acad. Sci. 107, 7407–7412. 10.1073/pnas.0910621107.
39. Slavoff, S.A., Mitchell, A.J., Schwaid, A.G., Cabili, M.N., Ma, J., Levin, J.Z., Karger, A.D., Budnik, B.A., Rinn, J.L., and Saghatelian, A. (2013). Peptidomic discovery of short open reading frame-encoded peptides in human cells. Nat. Chem. Biol. 9, 59–64. 10.1038/nchembio.1120.
40. Chong, C., Müller, M., Pak, H., Harnett, D., Huber, F., Grun, D., Leleu, M., Auger, A., Arnaud, M., Stevenson, B.J., et al. (2020). Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat. Commun. 11, 1293. 10.1038/s41467-020-14968-9.
41. Ehx, G., Larouche, J.-D., Durette, C., Laverdure, J.-P., Hesnard, L., Vincent, K., Hardy, M.-P., Thériault, C., Rulleau, C., Lanoix, J., et al. (2021). Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes. Immunity 54, 737-752.e10. 10.1016/j.immuni.2021.03.001.
42. Barczak, W., Carr, S.M., Liu, G., Munro, S., Nicastri, A., Lee, L.N., Hutchings, C., Ternette, N., Klenerman, P., Kanapin, A., et al. (2023). Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nat. Commun. 14, 1078. 10.1038/s41467-023-36826-0.
43. Apcher, S., Daskalogianni, C., Lejeune, F., Manoury, B., Imhoos, G., Heslop, L., and Fåhraeus, R. (2011). Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc. Natl. Acad. Sci. U. S. A. 108, 11572–11577. 10.1073/pnas.1104104108.
44. Todoerti, K., Ronchetti, D., Favasuli, V., Maura, F., Morabito, F., Bolli, N., Taiana, E., and Neri, A. (2022). DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome. Haematologica 107, 921–932. 10.3324/haematol.2021.278342.
45. Natsume, T., Kiyomitsu, T., Saga, Y., and Kanemaki, M.T. (2016). Rapid Protein Depletion in Human Cells by Auxin-Inducible Degron Tagging with Short Homology Donors. Cell Rep. 15, 210–218. 10.1016/j.celrep.2016.03.001.
46. Chang, C.-T., Muthukumar, S., Weber, R., Levdansky, Y., Chen, Y., Bhandari, D., Igreja, C., Wohlbold, L., Valkov, E., and Izaurralde, E. (2019). A low-complexity region in human XRN1 directly recruits deadenylation and decapping factors in 5’-3’ messenger RNA decay. Nucleic Acids Res. 47, 9282–9295. 10.1093/nar/gkz633.
47. Kalisiak, K., Kuliński, T.M., Tomecki, R., Cysewski, D., Pietras, Z., Chlebowski, A., Kowalska, K., and Dziembowski, A. (2017). A short splicing isoform of HBS1L links the cytoplasmic exosome and SKI complexes in humans. Nucleic Acids Res. 45, 2068–2080. 10.1093/nar/gkw862.
48. Davidson, L., Francis, L., Cordiner, R.A., Eaton, J.D., Estell, C., Macias, S., Cáceres, J.F., and West, S. (2019). Rapid Depletion of DIS3, EXOSC10, or XRN2 Reveals the Immediate Impact of Exoribonucleolysis on Nuclear RNA Metabolism and Transcriptional Control. Cell Rep. 26, 2779-2791.e5. 10.1016/j.celrep.2019.02.012.
49. Gagnon, K.T., Li, L., Janowski, B.A., and Corey, D.R. (2014). Analysis of nuclear RNA interference in human cells by subcellular fractionation and Argonaute loading. Nat. Protoc. 9, 2045–2060. 10.1038/nprot.2014.135.
50. Shao, M., and Kingsford, C. (2017). Accurate assembly of transcripts through phase-preserving graph decomposition. Nat. Biotechnol. 35, 1167–1169. 10.1038/nbt.4020.
51. Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15. 10.1186/s13059-014-0550-8.
52. Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., et al. (2014). An atlas of active enhancers across human cell types and tissues. Nature 507, 455–461. 10.1038/nature12787.
53. Lidschreiber, K., Jung, L.A., von der Emde, H., Dave, K., Taipale, J., Cramer, P., and Lidschreiber, M. (2021). Transcriptionally active enhancers in human cancer cells. Mol. Syst. Biol. 17, e9873. 10.15252/msb.20209873.
54. Preker, P., Nielsen, J., Kammler, S., Lykke-Andersen, S., Christensen, M.S., Mapendano, C.K., Schierup, M.H., and Jensen, T.H. (2008). RNA Exosome Depletion Reveals Transcription Upstream of Active Human Promoters. Science 322, 1851–1854. 10.1126/science.1164096.
55. Lorenzi, L., Chiu, H.-S., Avila Cobos, F., Gross, S., Volders, P.-J., Cannoodt, R., Nuytens, J., Vanderheyden, K., Anckaert, J., Lefever, S., et al. (2021). The RNA Atlas expands the catalog of human non-coding RNAs. Nat. Biotechnol. 39, 1453–1465. 10.1038/s41587-021-00936-1.
56. Tsanov, N., Samacoits, A., Chouaib, R., Traboulsi, A.-M., Gostan, T., Weber, C., Zimmer, C., Zibara, K., Walter, T., Peter, M., et al. (2016). smiFISH and FISH-quant - a flexible single RNA detection approach with super-resolution capability. Nucleic Acids Res. 44, e165. 10.1093/nar/gkw784.
57. Lee, S., Liu, B., Lee, S., Huang, S.-X., Shen, B., and Qian, S.-B. (2012). Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution. Proc. Natl. Acad. Sci. U. S. A. 109, E2424-2432. 10.1073/pnas.1207846109.
58. Ingolia, N.T., Lareau, L.F., and Weissman, J.S. (2011). Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147. 10.1016/j.cell.2011.10.002.
59. Luo, X., Huang, Y., Li, H., Luo, Y., Zuo, Z., Ren, J., and Xie, Y. (2022). SPENCER: a comprehensive database for small peptides encoded by noncoding RNAs in cancer patients. Nucleic Acids Res. 50, D1373–D1381. 10.1093/nar/gkab822.
60. Lv, D., Chang, Z., Cai, Y., Li, J., Wang, L., Jiang, Q., Xu, K., Ding, N., Li, X., Xu, J., et al. (2022). TransLnc: a comprehensive resource for translatable lncRNAs extends immunopeptidome. Nucleic Acids Res. 50, D413–D420. 10.1093/nar/gkab847.
61. Mudge, J.M., Ruiz-Orera, J., Prensner, J.R., Brunet, M.A., Gonzalez, J.M., Magrane, M., Martinez, T., Schulz, J.F., Yang, Y.T., Albà, M.M., et al. (2021). A community-driven roadmap to advance research on translated open reading frames detected by Ribo-seq. 2021.06.10.447896. 10.1101/2021.06.10.447896.
62. Sandmann, C.-L., Schulz, J.F., Ruiz-Orera, J., Kirchner, M., Ziehm, M., Adami, E., Marczenke, M., Christ, A., Liebe, N., Greiner, J., et al. (2023). Evolutionary origins and interactomes of human, young microproteins and small peptides translated from short open reading frames. Mol. Cell 83, 994-1011.e18. 10.1016/j.molcel.2023.01.023.
63. Walker, B.A., Mavrommatis, K., Wardell, C.P., Ashby, T.C., Bauer, M., Davies, F.E., Rosenthal, A., Wang, H., Qu, P., Hoering, A., et al. (2018). Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood 132, 587–597. 10.1182/blood-2018-03-840132.
64. Robinson, S.R., Viegas, S.C., Matos, R.G., Domingues, S., Bedir, M., Stewart, H.J.S., Chevassut, T.J., Oliver, A.W., Arraiano, C.M., and Newbury, S.F. (2018). DIS3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers. Biochem. J. 475, 2091–2105. 10.1042/BCJ20170962.
65. Pertesi, M., Vallée, M., Wei, X., Revuelta, M.V., Galia, P., Demangel, D., Oliver, J., Foll, M., Chen, S., Perrial, E., et al. (2019). Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma. Leukemia 33, 2324–2330. 10.1038/s41375-019-0452-6.
66. Boyle, E.M., Ashby, C., Tytarenko, R.G., Deshpande, S., Wang, H., Wang, Y., Rosenthal, A., Sawyer, J., Tian, E., Flynt, E., et al. (2020). BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 26, 2422–2432. 10.1158/1078-0432.CCR-19-1507.
67. White, B.S., Lanc, I., O’Neal, J., Gupta, H., Fulton, R.S., Schmidt, H., Fronick, C., Belter, E.A., Fiala, M., King, J., et al. (2018). A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5. Blood Cancer J. 8, 35. 10.1038/s41408-018-0062-y.
68. Weißbach, S., Langer, C., Puppe, B., Nedeva, T., Bach, E., Kull, M., Bargou, R., Einsele, H., Rosenwald, A., Knop, S., et al. (2015). The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma. Br. J. Haematol. 169, 57–70. 10.1111/bjh.13256.
69. Tomecki, R., Drazkowska, K., Kucinski, I., Stodus, K., Szczesny, R.J., Gruchota, J., Owczarek, E.P., Kalisiak, K., and Dziembowski, A. (2014). Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA metabolism and suggest hDIS3 PIN domain as a potential drug target. Nucleic Acids Res. 42, 1270–1290. 10.1093/nar/gkt930.
70. Höllein, A., Twardziok, S.O., Walter, W., Hutter, S., Baer, C., Hernandez-Sanchez, J.M., Meggendorfer, M., Haferlach, T., Kern, W., and Haferlach, C. (2020). The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time? Cancer Genet. 242, 15–24. 10.1016/j.cancergen.2020.01.001.
71. Bray, N.L., Pimentel, H., Melsted, P., and Pachter, L. (2016). Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525–527. 10.1038/nbt.3519.
72. Wang, M., Zhao, Y., and Zhang, B. (2015). Efficient Test and Visualization of Multi-Set Intersections. Sci. Rep. 5, 16923. 10.1038/srep16923.
73. Reynisson, B., Alvarez, B., Paul, S., Peters, B., and Nielsen, M. (2020). NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449–W454. 10.1093/nar/gkaa379.
74. Hoof, I., Peters, B., Sidney, J., Pedersen, L.E., Sette, A., Lund, O., Buus, S., and Nielsen, M. (2009). NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61, 1–13. 10.1007/s00251-008-0341-z.
75. Kong, A.T., Leprevost, F.V., Avtonomov, D.M., Mellacheruvu, D., and Nesvizhskii, A.I. (2017). MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry–based proteomics. Nat. Methods 14, 513–520. 10.1038/nmeth.4256.
76. Bouwmeester, R., Gabriels, R., Hulstaert, N., Martens, L., and Degroeve, S. (2021). DeepLC can predict retention times for peptides that carry as-yet unseen modifications. Nat. Methods 18, 1363–1369. 10.1038/s41592-021-01301-5.
77. Desiere, F., Deutsch, E.W., King, N.L., Nesvizhskii, A.I., Mallick, P., Eng, J., Chen, S., Eddes, J., Loevenich, S.N., and Aebersold, R. (2006). The PeptideAtlas project. Nucleic Acids Res. 34, D655–D658. 10.1093/nar/gkj040.
78. Schmidt, T., Samaras, P., Dorfer, V., Panse, C., Kockmann, T., Bichmann, L., van Puyvelde, B., Perez-Riverol, Y., Deutsch, E.W., Kuster, B., et al. (2021). Universal Spectrum Explorer: A Standalone (Web-)Application for Cross-Resource Spectrum Comparison. J. Proteome Res. 20, 3388–3394. 10.1021/acs.jproteome.1c00096.
79. Andreatta, M., Alvarez, B., and Nielsen, M. (2017). GibbsCluster: unsupervised clustering and alignment of peptide sequences. Nucleic Acids Res. 45, W458–W463. 10.1093/nar/gkx248.
80. Alvarez, B., Reynisson, B., Barra, C., Buus, S., Ternette, N., Connelley, T., Andreatta, M., and Nielsen, M. (2019). NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions. Mol. Cell. Proteomics MCP 18, 2459–2477. 10.1074/mcp.TIR119.001658.
81. Tuck, A.C., Rankova, A., Arpat, A.B., Liechti, L.A., Hess, D., Iesmantavicius, V., Castelo-Szekely, V., Gatfield, D., and Bühler, M. (2020). Mammalian RNA Decay Pathways Are Highly Specialized and Widely Linked to Translation. Mol. Cell 77, 1222-1236.e13. 10.1016/j.molcel.2020.01.007.
82. Ogami, K., Richard, P., Chen, Y., Hoque, M., Li, W., Moresco, J.J., Yates, J.R., Tian, B., and Manley, J.L. (2017). An Mtr4/ZFC3H1 complex facilitates turnover of unstable nuclear RNAs to prevent their cytoplasmic transport and global translational repression. Genes Dev. 31, 1257–1271. 10.1101/gad.302604.117.
83. Silla, T., Karadoulama, E., Mąkosa, D., Lubas, M., and Jensen, T.H. (2018). The RNA Exosome Adaptor ZFC3H1 Functionally Competes with Nuclear Export Activity to Retain Target Transcripts. Cell Rep. 23, 2199–2210. 10.1016/j.celrep.2018.04.061.
84. Fan, J., Kuai, B., Wu, G., Wu, X., Chi, B., Wang, L., Wang, K., Shi, Z., Zhang, H., Chen, S., et al. (2017). Exosome cofactor hMTR4 competes with export adaptor ALYREF to ensure balanced nuclear RNA pools for degradation and export. EMBO J. 36, 2870–2886. 10.15252/embj.201696139.
85. Andersen, P.R., Domanski, M., Kristiansen, M.S., Storvall, H., Ntini, E., Verheggen, C., Schein, A., Bunkenborg, J., Poser, I., Hallais, M., et al. (2013). The human cap-binding complex is functionally connected to the nuclear RNA exosome. Nat. Struct. Mol. Biol. 20, 1367–1376. 10.1038/nsmb.2703.
86. Passmore, L.A., and Coller, J. (2022). Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression. Nat. Rev. Mol. Cell Biol. 23, 93–106. 10.1038/s41580-021-00417-y.
87. Ibrahim, F., Maragkakis, M., Alexiou, P., and Mourelatos, Z. (2018). Ribothrypsis, a novel process of canonical mRNA decay, mediates ribosome-phased mRNA endonucleolysis. Nat. Struct. Mol. Biol. 25, 302–310. 10.1038/s41594-018-0042-8.
88. Boussi, L.S., Avigan, Z.M., and Rosenblatt, J. (2022). Immunotherapy for the treatment of multiple myeloma. Front. Immunol. 13. 10.3389/fimmu.2022.1027385.
89. Keats, J.J., Speyer, G., Christophe, L., Austin, C., Stephenson, K., Kurdoglu, A., Russell, M., Jessica, A., Lori, C., Adkins, J., et al. (2015). Identification of Initiating Trunk Mutations and Distinct Molecular Subtypes: An Interim Analysis of the Mmrf Commpass Study. Blood 126, 722. 10.1182/blood.V126.23.722.722.
90. Keats, J.J., Speyer, G., Christofferson, A., Legendre, C., Aldrich, J., Russell, M., Cuyugan, L., Adkins, J., Blanski, A., Hodges, M., et al. (2016). Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study. Blood 128, 194. 10.1182/blood.V128.22.194.194.
91. Keats, J.J., Craig, D.W., Liang, W., Venkata, Y., Kurdoglu, A., Aldrich, J., Auclair, D., Allen, K., Harrison, B., Jewell, S., et al. (2013). Interim Analysis Of The Mmrf Commpass Trial, a Longitudinal Study In Multiple Myeloma Relating Clinical Outcomes To Genomic and Immunophenotypic Profiles. Blood 122, 532. 10.1182/blood.V122.21.532.532.
92. Lonial, S., Yellapantula, V.D., Liang, W., Kurdoglu, A., Aldrich, J., Legendre, C.M., Stephenson, K., Adkins, J., McDonald, J., Helland, A., et al. (2014). Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression. Blood 124, 722. 10.1182/blood.V124.21.722.722.
93. Scientific Image and Illustration Software | BioRender https://www.biorender.com/.
94. Weick, E.-M., Puno, M.R., Januszyk, K., Zinder, J.C., DiMattia, M.A., and Lima, C.D. (2018). Helicase-Dependent RNA Decay Illuminated by a Cryo-EM Structure of a Human Nuclear RNA Exosome-MTR4 Complex. Cell 173, 1663-1677.e21. 10.1016/j.cell.2018.05.041.
95. Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E. (2004). UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612. 10.1002/jcc.20084.
96. Ittisoponpisan, S., Islam, S.A., Khanna, T., Alhuzimi, E., David, A., and Sternberg, M.J.E. (2019). Can Predicted Protein 3D Structures Provide Reliable Insights into whether Missense Variants Are Disease Associated? J. Mol. Biol. 431, 2197–2212. 10.1016/j.jmb.2019.04.009.
97. Yang, K.L., Yu, F., Teo, G.C., Demichev, V., Ralser, M., and Nesvizhskii, A.I. (2022). MSBooster: Improving Peptide Identification Rates using Deep Learning-Based Features. 2022.10.19.512904. 10.1101/2022.10.19.512904.
98. Imbert, A., Ouyang, W., Safieddine, A., Coleno, E., Zimmer, C., Bertrand, E., Walter, T., and Mueller, F. (2022). FISH-quant v2: a scalable and modular tool for smFISH image analysis. RNA N. Y. N 28, 786–795. 10.1261/rna.079073.121.
99. Gerlach, P., Schuller, J.M., Bonneau, F., Basquin, J., Reichelt, P., Falk, S., and Conti, E. (2018). Distinct and evolutionary conserved structural features of the human nuclear exosome complex. eLife 7, e38686. 10.7554/eLife.38686.
100. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., and Gingeras, T.R. (2013). STAR: ultrafast universal RNA-seq aligner. Bioinforma. Oxf. Engl. 29, 15–21. 10.1093/bioinformatics/bts635.
101. Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel, H., Salzberg, S.L., Rinn, J.L., and Pachter, L. (2012). Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578. 10.1038/nprot.2012.016.
102. Quinlan, A.R., and Hall, I.M. (2010). BEDTools: a flexible suite of utilities for comparing genomic features. Bioinforma. Oxf. Engl. 26, 841–842. 10.1093/bioinformatics/btq033.
103. Wickham, H. (2009). ggplot2: Elegant Graphics for Data Analysis (Springer) 10.1007/978-0-387-98141-3.
104. Choudhary, S., Li, W., and D Smith, A. (2020). Accurate detection of short and long active ORFs using Ribo-seq data. Bioinforma. Oxf. Engl. 36, 2053–2059. 10.1093/bioinformatics/btz878.
105. Liao, Y., Smyth, G.K., and Shi, W. (2014). featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinforma. Oxf. Engl. 30, 923–930. 10.1093/bioinformatics/btt656.
106. Gu, Z. (2022). Complex heatmap visualization. iMeta 1, e43. 10.1002/imt2.43.
107. Hecker, N., and Hiller, M. (2020). A genome alignment of 120 mammals highlights ultraconserved element variability and placenta-associated enhancers. GigaScience 9, giz159. 10.1093/gigascience/giz159.
108. Boegel, S., Löwer, M., Schäfer, M., Bukur, T., de Graaf, J., Boisguérin, V., Türeci, Ö., Diken, M., Castle, J.C., and Sahin, U. (2012). HLA typing from RNA-Seq sequence reads. Genome Med. 4, 102. 10.1186/gm403.